<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties manuscript?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-journal-id">101189458</journal-id><journal-id journal-id-type="pubmed-jr-id">31897</journal-id><journal-id journal-id-type="nlm-ta">J Occup Environ Hyg</journal-id><journal-id journal-id-type="iso-abbrev">J Occup Environ Hyg</journal-id><journal-title-group><journal-title>Journal of occupational and environmental hygiene</journal-title></journal-title-group><issn pub-type="ppub">1545-9624</issn><issn pub-type="epub">1545-9632</issn></journal-meta><article-meta><article-id pub-id-type="pmid">40245411</article-id><article-id pub-id-type="pmc">12353224</article-id><article-id pub-id-type="doi">10.1080/15459624.2025.2485074</article-id><article-id pub-id-type="manuscript">HHSPA2075764</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Use of portable air cleaners within an ambulance workspace</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Pena</surname><given-names>Mirle</given-names></name><xref rid="A1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Neu</surname><given-names>Dylan T.</given-names></name><xref rid="A1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Amy Feng</surname><given-names>H.</given-names></name><xref rid="A1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Hammond</surname><given-names>Duane R.</given-names></name><xref rid="A1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Mead</surname><given-names>Kenneth R.</given-names></name><xref rid="A1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Banerjee</surname><given-names>Rupak K.</given-names></name><xref rid="A2" ref-type="aff">b</xref></contrib></contrib-group><aff id="A1"><label>a</label>Division of Field Studies and Engineering, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Cincinnati, OH</aff><aff id="A2"><label>b</label>Department of Mechanical and Biomedical Engineering, University of Cincinnati, Cincinnati, OH</aff><author-notes><fn fn-type="con" id="FN1"><p id="P1">Author contributions</p><p id="P2">M.P.: Conceptualization, Methodology, Investigation, Data Curation, Writing&#x02014;Original Draft Preparation, Writing&#x02014;Review and Editing, D.T.N.: Methodology, Investigation, Data Curation, Writing&#x02014;Original Draft Preparation, Writing&#x02014;Review and Editing, A.F.: Data Curation, D.R.H.-Methodology, Investigation, Writing&#x02014;Review and Editing, K.R.M.: Methodology, Investigation, Writing&#x02014;Review and Editing, R.K.B.: Conceptualization, Methodology, Investigation, Writing&#x02014;Review and Editing. All authors have read and agreed to the published version of the manuscript.</p></fn><corresp id="CR1"><bold>CONTACT</bold> Dylan T Neu, <email>DNeu@cdc.gov</email>, Division of Field Studies and Engineering, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, 1090 Tusculum Ave, MS-R5, Cincinnati, OH 45226.</corresp></author-notes><pub-date pub-type="nihms-submitted"><day>6</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="epub"><day>17</day><month>4</month><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>15</day><month>8</month><year>2025</year></pub-date><fpage>1</fpage><lpage>14</lpage><abstract id="ABS1"><p id="P3">Emergency medical service (EMS) providers face significant exposure to infectious aerosols during outbreaks like the COVID-19 pandemic. Most ambulances lack ventilation controls to reduce EMS worker exposure to these aerosols. Ambulances are smaller than hospital rooms and handle numerous patients daily, increasing contact with potentially infectious individuals. Ventilation controls such as portable high-efficiency particulate air (HEPA) filtration can mitigate this risk. Few studies have assessed portable HEPA filters in ambulances. This study evaluated two HEPA filter models in an unoccupied, stationary research ambulance at the National Institute for Occupational Safety and Health (NIOSH) in Cincinnati. A tracer aerosol simulated patient aerosol generation, and optical particle counters (OPCs) measured aerosols. The HEPA units were tested individually, placed in the same location, and operated for 50 min. Results showed significant reductions in aerosol concentrations during the generation phase, with performance varying during the decay period. Overall, HEPA units reduced particle concentrations by around 50% during the generation phase and continued to be effective through the decay period. This demonstrates the potential of portable HEPA filters as an affordable and effective option for air cleaning in ambulance patient modules.</p></abstract><kwd-group><kwd>Ambulance</kwd><kwd>bioaerosol</kwd><kwd>EMS</kwd><kwd>HEPA filtration</kwd><kwd>infection control</kwd><kwd>ventilation</kwd></kwd-group></article-meta></front><body><sec id="S1"><title>Introduction</title><p id="P4">The importance of ventilation systems in reducing the transmission of infectious aerosols has been investigated over decades of research and brought to wider attention by the COVID-19 pandemic. Using portable air cleaners with high-efficiency particulate air (HEPA) filters has been a recommended ventilation control strategy for indoor settings. They can improve indoor air quality by removing 99.97% or more of particulates from the air they filter (<xref rid="R15" ref-type="bibr">Environmental Protection Agency 2021</xref>, <xref rid="R16" ref-type="bibr">2023</xref>). These air cleaners can filter infectious aerosols to reduce exposure to bacteria and viruses, including SARS-CoV-2, the virus that causes COVID-19, influenza, and respiratory syncytial virus (RSV). These illnesses are transmitted when an infected person breathes out droplets and very small particles that contain the pathogen and a susceptible individual subsequently comes into contact with that pathogen, primarily through inhalation (<xref rid="R7" ref-type="bibr">Centers for Disease Control and Prevention 2021</xref>; <xref rid="R26" ref-type="bibr">Lee 2020</xref>; <xref rid="R36" ref-type="bibr">National Center for Immunization and Respiratory Diseases (NCIRD) 2022</xref>).</p><p id="P5">Emergency medical service (EMS) providers have the potential for significant exposure to infectious aerosols when treating emergency patients (<xref rid="R34" ref-type="bibr">Maudet et al. 2020</xref>). The traditional ambulance layout consists of the captain&#x02019;s seat (where OPC-1 is located), the CPR seat (where OPC-2 is located), and the bench seat (where OPC-3 and OPC-4 are located) (<xref rid="R22" ref-type="bibr">Kibira et al. 2013</xref>). EMS providers need to face and have within reach the patient; therefore, the closest locations are OPC-1, OPC-2, and OPC-3. These locations allow the providers to reach the patient&#x02019;s body and provide medical care during transport. OPC-2 is the seat for cardiopulmonary resuscitation which is not often used (<xref rid="R23" ref-type="bibr">Kibira et al. 2012</xref>).</p><p id="P6">They may perform aerosol-generating procedures such as endotracheal intubation that may generate infectious aerosols and droplets leading to increased risk of exposure (<xref rid="R14" ref-type="bibr">El-Boghdadly et al. 2020</xref>; <xref rid="R32" ref-type="bibr">Luo et al. 2020</xref>; <xref rid="R37" ref-type="bibr">Ng et al. 2020</xref>; <xref rid="R41" ref-type="bibr">Weissman et al. 2020</xref>). Although EMS providers use personal protective equipment to reduce exposure to SARS-CoV-2, further preventive measures need to be applied (<xref rid="R4" ref-type="bibr">Buick et al. 2020</xref>). Ambulances with air cleaning technology, such as built-in HEPA filters exist but are uncommon in practice and it can be relatively expensive for EMS providers to replace an ambulance or entire fleet of ambulances with newer models with these features (<xref rid="R20" ref-type="bibr">Horton Ambulances 2021</xref>; <xref rid="R42" ref-type="bibr">Wheeled Coach 2022</xref>; <xref rid="R1" ref-type="bibr">Ambulancemed 2023</xref>; <xref rid="R39" ref-type="bibr">RMA Group 2023</xref>). Many ambulances on the road have heating and cooling systems that simply recirculate the air and do not exchange it with outdoor air. Some manufacturers have started to install custom-made HEPA filtration on already constructed ambulances (<xref rid="R40" ref-type="bibr">Webasto Thermo &#x00026; Comfort 2023</xref>). Nevertheless, more independent data are needed on the effectiveness and cost of different air cleaning technologies for ambulance patient modules.</p><p id="P7">For EMS providers that have not purchased a new ambulance with HEPA filtration or are waiting on a retrofit, another potential temporary option could be the implementation of portable HEPA air cleaners. Many studies have demonstrated the effectiveness of portable HEPA air cleaners in removing air contaminants (<xref rid="R10" ref-type="bibr">Cox et al. 2018</xref>; <xref rid="R3" ref-type="bibr">Bluyssen et al. 2021</xref>; <xref rid="R5" ref-type="bibr">Cadnum et al. 2023</xref>). More specifically, studies simulating SARS-CoV-2 virus exposure have been performed to evaluate air cleaning in different settings (<xref rid="R9" ref-type="bibr">Chen et al. 2010</xref>; <xref rid="R29" ref-type="bibr">Lindsley et al. 2021</xref>; <xref rid="R30" ref-type="bibr">Liu et al. 2022</xref>). Very few studies have evaluated ventilation controls in moving vehicles. A previous NIOSH study showed that a ventilation system inside an ambulance could reduce exposure to infectious aerosols (<xref rid="R28" ref-type="bibr">Lindsley et al. 2019</xref>). Air cleaners have also been studied in a school bus to reduce aerosol exposure in children (<xref rid="R27" ref-type="bibr">Lee et al. 2015</xref>). To our authors&#x02019; knowledge, no additional research has been done on vehicular ventilation to control infectious aerosols. Therefore, there is a clear need to study the effects of ventilation controls in moving transportation vehicles, especially in ambulances, where exposure to infectious aerosols is likely to be higher than in similar healthcare treatment spaces within a building. Methods to evaluate the efficiency of HEPA filtration in these spaces include the use of mathematical modeling (e.g. computational fluid dynamics) (<xref rid="R9" ref-type="bibr">Chen et al. 2010</xref>) and nebulization of polystyrene particles measured with particle counters and aerodynamic particle sizers (<xref rid="R35" ref-type="bibr">Mead and Johnson 2004</xref>; <xref rid="R19" ref-type="bibr">Heo et al. 2021</xref>; <xref rid="R29" ref-type="bibr">Lindsley et al. 2021</xref>).</p><p id="P8">To further protect EMS personnel, the Centers for Disease Control and Prevention (CDC) has suggested opening the ambulance&#x02019;s doors after patient discharge at the hospital; thereby increasing air exchange and removing potential infectious aerosols inside the ambulance patient module (<xref rid="R6" ref-type="bibr">Centers for Disease Control and Prevention 2019</xref>, <xref rid="R8" ref-type="bibr">2023</xref>). Portable HEPA filtration units could supplement the air exchange rate while in transit when it is not feasible to have the rear doors open and thus, could improve air quality and reduce worker exposure to infectious aerosols.</p><p id="P9">In the present article, we evaluated separately two different models of portable HEPA filtration units inside the patient module were evaluated separately. The portable HEPA filtration units had different characteristics such as clean air delivery rates (CADR) and induced airflow paths.</p></sec><sec id="S2"><title>Materials and methods</title><sec id="S3"><title>Air filtration intervention</title><sec id="S4"><title>Portable HEPA filtration units</title><p id="P10">Two different portable HEPA filtration units were evaluated and can be observed in <xref rid="F1" ref-type="fig">Figure 1</xref>. The first one was identified as HEPA-1 (Smart Purifier Bissell, Walker, MI) (<xref rid="F1" ref-type="fig">Figure 1A</xref> and <xref rid="F1" ref-type="fig">B</xref>, left); and the second one as HEPA-2 (GermGuardian, Guardian Technologies, Euclid, OH) (<xref rid="F1" ref-type="fig">Figure 1A</xref> and <xref rid="F1" ref-type="fig">B</xref>, right). The HEPA filtration units differed in a few ways: (1) manufacturer provided clean air delivery rates (CADRs) and measured face velocities across the outlet surface [HEPA-1 (172 CADR, 230-1350 feet per min) and HEPA-2 (99 CADR, 330-1100 feet per min)]; (2) HEPA filter sizes (<xref rid="F1" ref-type="fig">Figure 1A</xref>); and (3) induced airflow direction. &#x0201c;Induced airflow&#x0201d; describes how air is drawn into and expelled from a HEPA filtration unit, and how this process alters the patterns of airflow in the surrounding environment. The induced airflow direction may impact the overall effectiveness of the unit if the airflow does not allow for proper room circulation. For example, HEPA-1&#x02019;s inlet was located in the front which included the whole front face, and the outlet was located at the top which resulted in air expelled upwards. HEPA-2&#x02019;s inlet was located on the back (had a smaller inlet size relative to HEPA-1) and the outlets were located on the left and right sides of the unit which resulted in air expelled from two sides (left and right) with smaller openings (<xref rid="F1" ref-type="fig">Figure 1B</xref>). The filtered air expelled from the sides could get re-circulated due to the proximity to the inlet face, meaning air that has already been filtered would be filtered again instead of mixing with the ambient air, also referred to as &#x0201c;short-circuiting.&#x0201d; Induced airflow can also cause inadvertent increases in the relatively small space of exposure in the ambulance. Induced airflow may result in patient-generated bioaerosols being pulled or pushed through a worker&#x02019;s breathing zone.</p><p id="P11">Commercially available HEPA filtration units differ in a variety of ways including size and shape, and shape, inlet and outlet direction, and CADR. Given the small space and organizational needs of the ambulance cabin, the HEPA filtration units needed to fit in this space to prevent interference and must not interfere with the workflow of EMS providers or cause a trip hazard. Thus, the corner behind OPC-1 was the most preferable location to place the units; see <xref rid="F2" ref-type="fig">Figure 2</xref>. This constraint considerably limits the number of available units that work available for use in the ambulance space. Two commercially available off-the-shelf HEPA filtration units were chosen from commercially available off-the-shelf options that fit within the confines of the space behind the rear-facing jump seat in the ambulance, as well as providing a range of CADRs. HEPA-1 was placed so the air inlet would be facing face the ambulance cabin behind OPC-1. The HEPA-2, to avoid creating a recirculation zone due to limited space, the unit was placed sideways in the corner behind OPC-1 to avoid creating a recirculation zone due to limited space (<xref rid="F2" ref-type="fig">Figure 2</xref>).</p></sec></sec><sec id="S5"><title>Equipment and instrumentation</title><sec id="S6"><title>Nebulizers</title><p id="P12">The applied nebulization protocol was previously described in <xref rid="R38" ref-type="bibr">Pena et al. (2023)</xref>. Two medical nebulizers (Model 85B 0000, PARI Innovative Manufacturing Inc., Midlothian, VA) and nebulizing cups were used to simulate a patient&#x02019;s aerosol generation. 1.6 to generate the droplet nuclei of 1.6 &#x003bc;m polystyrene latex (PSL) microspheres (4016 A Monosized Particles, Thermo Scientific) with a particle density of 1.05 g/cm<sup>3</sup> and size distribution of &#x000b1;0.021 &#x003bc;m were used to generate the droplet nuclei. This particle size was selected as it is representative of infectious aerosols that can remain airborne for long periods, are readily inhaled, and are capable of deep lung deposition within the human respiratory tract (<xref rid="R35" ref-type="bibr">Mead and Johnson 2004</xref>).</p></sec></sec><sec id="S7"><title>Optical particle counters</title><p id="P13">To obtain particle concentration measurements, four OPCs were used (model 11-D GRIMM Aerosol Technik, Ainring, Germany). The instruments have 31 equidistant channels and can detect particles of sizes ranging from 0.253 to 35.15 &#x003bc;m, through light scattering. The OPCs were programmed to log data every 6 six seconds to provide an average particle concentration in particle number concentration (particles/L). Since the tracer aerosol had a particle size of 1.6 &#x003bc;m, the channel of interest was from 1.545 to 1.821 &#x003bc;m since the tracer aerosol had a particle size of 1.6 &#x003bc;m and only that size channel was analyzed for this study.</p><p id="P14">To measure particle concentrations at the breathing zone level of the EMS providers when inside the ambulance, NIOSH engineers developed four platforms of medium-density fiberboard and aluminum framing (80/20 Inc., Columbia City, IN). The platforms were situated on four seats inside the ambulance and the OPCs were placed on top. The height of the platforms was determined with height measurements from the American Industrial Hygiene Association (AIHA) Engineering Reference Manual which has anthropometric data from the U.S. (<xref rid="R17" ref-type="bibr">Estill 1999</xref>). The data measurements initially considered were from the 95th percentile for women and the 50th percentile for men. Because the sitting eye height and sitting knee height were very similar for both male and female populations, the 95th percentile women&#x02019;s measurements were used. Finally, the sitting eye height (31&#x02033; in 78.74 cm) was added to the sitting knee height (21.5&#x02033; in 54.61 cm) minus 2&#x02033; in (5.08 cm) for the mouth level to obtain a final breathing zone height. Therefore, the final height of the platforms at which the OPCs were placed was 50.5&#x02033; in (128.27 cm) above the floor of the module.</p></sec><sec id="S8"><title>Ambulance</title><p id="P15">A type III ambulance (Wheeled Coach, Winter Park, FL) was used to evaluate the effectiveness of the portable HEPA units in reducing aerosol concentrations in the patient module. The ambulance was parked outside at the NIOSH facility located in Cincinnati, Ohio, and was connected to 120 V shoreline power during the experiments. Before all the experiments, openings in the patient module were sealed with aluminum foil tape including all, including exterior ports. This was to reduce the infiltration of environmental aerosols that could confound measurement results. Before each test, the ambulance engine was turned on to power the cooling compressor within the HVAC system, and the HVAC fan system was turned on and set to the highest airflow setting with the thermostat set to 75&#x000b0;F. The HVAC fan was a recirculating system and pulls with no outdoor air used for heating and cooling. To simulate a patient inside the module, a mannequin was placed on the patient&#x02019;s stretcher. To control the nebulizer air pumps from outside the ambulance, the power cords were routed through a port located at the side of the ambulance patient module. The nebulizing cups were placed one on each side of the mannequin&#x02019;s face at the height of the mouth. The OPCs were placed on top of the platforms at each measurement location (shown in <xref rid="F2" ref-type="fig">Figure 2</xref>) and turned on for particle sampling. Finally, the ambulance doors were closed, and the experiment was initiated.</p><p id="P16">For purposes of documenting environmental consistency, the temperature and relative humidity were collected with the HOBO H8 Pro Series loggers (MicroDAQ.com Ltd, Warner, NH) during each test to monitor the HVAC system. The temperature data were not used to assess the filtration systems but were used to troubleshoot any issues during the experimental set-up. The experiments were performed when outdoor temperatures were equal to or greater than 68&#x000b0;F (<bold>20</bold>&#x000b0;<bold>C</bold>). Therefore, the ambulance HVAC system was in cooling mode when performing the tests throughout the entirety of each test.</p></sec><sec id="S9"><title>Experimental setup</title><p id="P17"><xref rid="F2" ref-type="fig">Figure 2A</xref> shows the ambulance layout with the location where portable HEPA filtration units were placed behind the rear-facing EMS provider seat. Exact airflow directions into HEPA-1 and HEPA-2 differ but both units pull air from the air directly surrounding them. The arrows in <xref rid="F2" ref-type="fig">Figure 2A</xref> show the airflow direction of the HVAC system not the airflow direction of the HEPA filtration units. The arrows in <xref rid="F2" ref-type="fig">Figure 2B</xref> illustrate the airflow direction of the HEPA filtration units in place from inlet air (in yellow) to filtered air (in green). The ambulance was stationary for safety reasons while performing all experiments with the HEPA filter units.</p></sec><sec id="S10"><title>Experiments and data acquisition</title><p id="P18">Three experimental conditions were tested: (1) the baseline (without portable HEPA filtration units), (2) HEPA-1, and (3) HEPA-2. Once the experiment was finished, the OPC data were transferred and processed in a computer for the statistical analysis using SAS statistical software (Version 9.4, SAS Institute, Inc., Cary, NC).</p><p id="P19">The three conditions had 6 replicates each, making up a total of 18 tests. The completion order of the 18 tests was randomized by condition and 4&#x02013;5 tests were performed per day in the order of this randomized list, and across multiple days to account for varying climatic conditions.</p></sec><sec id="S11"><title>Baseline test condition</title><p id="P20">The general protocol consisted of three phases: (1) background particle removal, (2) aerosol generation, and (3) aerosol decay. During phase 1, the OPCs sampled background particle concentrations for 15 min without any HEPA filtration unit in place. In phase 2, the two nebulizers were turned on for 5 min for aerosol generation and then turned off. Finally, during phase 3 an aerosol decay was observed at three time intervals: 10, 20, and 30 min. Overall, a full experiment lasted 50 min.</p></sec><sec id="S12"><title>Portable HEPA filtration units test condition</title><p id="P21">For the portable HEPA filtration unit test condition, the same protocol for the baseline case was followed with the addition of only one portable air cleaner, either HEPA-1 or HEPA-2, activated at the start of phase 1 and left on throughout the entire experiment. Each test condition for HEPA-1 and HEPA-2 was evaluated six times (<italic toggle="yes">n</italic> = 6).</p></sec><sec id="S13"><title>Data analysis</title><sec id="S14"><title>Data processing</title><p id="P22">Particle count concentrations were measured during the background particle removal phase (phase 1) for each test. To establish a representative background concentration for analysis purposes, the last 3-min particle concentrations from phase 1 were averaged for each OPC on every replicate. This means four background OPC averages (OPC-1, OPC-2, OPC-3, and OPC-4) were obtained for every test. To account for the background concentrations in the data analyses, the representative background concentration for each OPC during each test was subtracted from each data point collected by that OPC throughout the subsequent phases of the experiment. This was done for each replicate and each condition. Negative concentration values were generated when the measured data point was less than the average background. The negative numbers were retained to avoid skewing the data that could diminish the real effect of the HEPA filtration units; thereby, showing HEPA filtration units reducing aerosol concentrations lower than background levels. Finally, a cabin average concentration (determined after the correction of background concentration) was calculated from the average of the four OPCs for each experiment and condition.</p><p id="P23">The overall reduction percentages were calculated for the baseline, HEPA-1, and HEPA-2 conditions. The background corrected mean concentration during the aerosol generation phase of the baseline was used as the 100%-concentration since it was the control condition and had the highest peak concentration. To obtain the percentage reduction, the background-corrected mean concentration of each phase of each condition was subtracted from the background-corrected mean concentration of the baseline aerosol generation phase (phase 2) and divided by the background-corrected mean concentration of the baseline aerosol generation phase (phase 2). The equation used is shown below.</p><disp-formula id="FD1">
<label>(1)</label>
<mml:math id="M1" display="block"><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">v</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">l</mml:mi><mml:mi mathvariant="normal">l</mml:mi><mml:mspace width="0.25em"/><mml:mi mathvariant="normal">p</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">c</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">g</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mspace width="0.25em"/><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">d</mml:mi><mml:mi mathvariant="normal">u</mml:mi><mml:mi mathvariant="normal">c</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mo>=</mml:mo><mml:mspace width="0.25em"/><mml:mfenced open="[" close="]" separators="|"><mml:mrow><mml:mfrac><mml:mrow><mml:mi mathvariant="normal">b</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">s</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">l</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mspace width="0.25em"/><mml:mi mathvariant="normal">A</mml:mi><mml:mi mathvariant="normal">G</mml:mi><mml:mspace width="0.25em"/><mml:mi mathvariant="normal">m</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mo>-</mml:mo><mml:mi mathvariant="normal">c</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mi mathvariant="normal">d</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mspace width="0.25em"/><mml:mi mathvariant="normal">p</mml:mi><mml:mi mathvariant="normal">h</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">s</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mspace width="0.25em"/><mml:mi mathvariant="normal">m</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">n</mml:mi></mml:mrow><mml:mrow><mml:mfenced separators="|"><mml:mrow><mml:mi mathvariant="normal">b</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">s</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">l</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mspace width="0.25em"/><mml:mi mathvariant="normal">A</mml:mi><mml:mi mathvariant="normal">G</mml:mi><mml:mspace width="0.25em"/><mml:mi mathvariant="normal">m</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">n</mml:mi></mml:mrow></mml:mfenced></mml:mrow></mml:mfrac></mml:mrow></mml:mfenced><mml:mo>&#x000d7;</mml:mo><mml:mn>100</mml:mn></mml:math>
</disp-formula></sec></sec><sec id="S15"><title>Statistical analysis</title><p id="P24">The statistical analyses were performed using SAS (Version 9.4, SAS Institute, Inc., Cary, NC), and one-way ANOVA with Tukey&#x02019;s Multiple Comparison tests were performed with a 95% CI and a level of significance of <italic toggle="yes">p</italic> &#x0003c; 0.05.</p></sec><sec id="S16"><title>Sulfur hexafluoride test</title><p id="P25">A tracer gas test was performed to measure air leakage in the ambulance. One percent Sulfur hexafluoride (SF<sub>6</sub>) was used as the tracer gas and a 1512 Photoacoustic Gas Monitor (Innova, LumaSense Technologies A/S, Ballerup, Denmark) sampled the SF<sub>6</sub> concentration in approximately 35 s intervals. SF<sub>6</sub> is a potent greenhouse gas with significant regulatory restrictions in California, Massachusetts (gas-insulated switchgear), New York (proposed), the European Union, and other jurisdictions due to its high global warming potential. The regulations primarily target reducing emissions from electric transmission and distribution systems. However, outside California and the EU, they do not cover the small fraction of SF6 used in research applications. SF<sub>6</sub> is a gas and as such would not be removed via mechanical filtration like a HEPA filter. Its use here is thus not as a test surrogate but only to measure outside air infiltration and provide context to particle measurements. For the experimental setup, the gas monitor was placed on the bench seat with one tube extension connected to four sampling ports with equally distant tube extensions to each location; each port was placed on the platform at each of the four locations. The ambulance engine was started, and the HVAC system was turned on at the highest flow setting. A portable axial fan was placed on the patient stretcher to facilitate air mixing and the doors were closed. Many standards and guidelines for tracer gas decay testing, such as those from ISO or ASTM, recommend or require the use of mixing fans to achieve uniform tracer gas distribution during the measurement process. Mixing fans help reduce measurement errors caused by localized air movement, such as drafts or temperature-driven convection currents, which could lead to an uneven distribution of SF<sub>6</sub>. A NIOSH engineer stayed inside the ambulance holding a gas sample bag filled with the 1% SF<sub>6</sub> tracer gas. The gas monitor was turned on and once it started sampling, the engineer opened the valve and squeezed the bag for approximately 7 sec, exited the ambulance with the SF<sub>6</sub> bag, and closed the doors. The engineer waited 30 sec to allow for the mixing of air in the ambulance before recording the data for the start time of the concentration decay curve. Then, the highest SF<sub>6</sub> concentration peak was recorded, and the concentration was monitored from outside the ambulance until the peak concentration was reduced by 99%. Six replicates (<italic toggle="yes">n</italic> = 6) of data were collected.</p></sec></sec><sec id="S17"><title>Results</title><p id="P26">The data presented in <xref rid="F3" ref-type="fig">Figure 3</xref> are background-corrected 5-point moving averages from the three test conditions (Baseline, HEPA-1, and HEPA-2) in particles/L versus time during all experimental phases.</p><p id="P27">The results reported here represent the average of the concentrations of the four locations (OPC-1, OPC-2, OPC-3, and OPC-4) inside the patient module and the six replicates of each condition. Particle concentrations in particles/L in this <xref rid="S17" ref-type="sec">results</xref> section are background-corrected values. Thus, a value of 00 particle/L means that the particle concentration was equal to the measured average concentration minus the background average concentration.</p><p id="P28">Overall, current results showed that HEPA-1 and HEPA-2 reduced peak aerosol concentration by 46&#x02013;55% during a 5 min simulated aerosol-generating procedure compared to without the presence of a portable HEPA filtration unit. The HEPA-1 and HEPA-2 continued to reduce the aerosol concentration over the following 30 min to below the background level.</p><sec id="S18"><title>Baseline</title><p id="P29">For the baseline case, a peak concentration of around 30 particles/L was observed during aerosol generation (phase 2) right before minute 20 (<xref rid="F3" ref-type="fig">Figure 3A</xref>). After the first 5 min of phase 3, the aerosol concentration went down to &#x0003c;5 particles/L, but the concentration continued to somewhat oscillate until the end of the phase.</p></sec><sec id="S19"><title>HEPA-1 and HEPA-2</title><p id="P30">Lower concentration peaks during aerosol generation (phase 2) can be observed for both HEPA-1 (&#x0003c;15 particle/L; <xref rid="F3" ref-type="fig">Figure 3B</xref>) and HEPA-2 (&#x0003c;20 particles/L; <xref rid="F3" ref-type="fig">Figure 3C</xref>) than for the Baseline condition (~30 particles/L; <xref rid="F3" ref-type="fig">Figure 3A</xref>). At the start of phase 3, HEPA-1 reached a concentration of around zero and continued to lower particle concentrations. HEPA-2 reached a concentration of &#x0003c;5 particles/L during the first 5 min of phase 3 and had a fluctuating decay with concentrations near zero for the rest of the phase.</p></sec><sec id="S20"><title>Average particle concentration of baseline, HEPA-1, and HEPA-2 conditions</title><p id="P31"><xref rid="F4" ref-type="fig">Figure 4</xref> shows the average concentrations in particles/L of the three conditions (baseline, HEPA-1, and HEPA-2) during the three phases of the experiment: background particle removal (phase 1), aerosol generation (phase 2), and decay (phase 3) at 10, 20, and 30 min. The background particle removal phase is included to observe the initial average particle concentrations before the aerosol generation phase. The baseline case, during aerosol generation, showed an average concentration of ~18 particles/L. In the first 10 min, it reduced the concentration to ~7 particles/L, and after 20 min below the background concentration.</p><p id="P32">During the aerosol generation phase, the HEPA-1 and HEPA-2 cases showed a reduction in particle concentrations to less than 10 particles/L. At 10 min, HEPA-1 reached a concentration below the background concentration and kept reducing the concentration throughout the rest of the decay phase. HEPA-2, on the other hand, reached a concentration of less than 5 particles/L after 10 min, and below background after 20 min.</p><p id="P33">There were statistical differences (<italic toggle="yes">p</italic> &#x0003c; 0.01) among conditions at all phases. During the background particle removal phase, the baseline case was statistically different than HEPA-1 but not from HEPA-2 (baseline condition having more particles/L, see <xref rid="F4" ref-type="fig">Figure 4</xref>), while the performance of the HEPA filtration units was statistically different from each other (HEPA-2 condition having more particles/L, see <xref rid="F4" ref-type="fig">Figure 4</xref>). Additionally, during aerosol generation, the particle concentration during the baseline case was statistically higher than HEPA-1 and HEPA-2, but there was no statistical difference among the HEPA filtration units. The concentrations from the HEPA-1 test condition were statistically lower than the baseline case at 10, 20, and 30 min (one-way ANOVA, <italic toggle="yes">p</italic> &#x0003c; 0.01). The concentrations from the HEPA-2 test condition were statistically lower than the baseline case only at 10 min (one-way ANOVA, <italic toggle="yes">p</italic> &#x0003c; 0.01). Particle concentrations from the HEPA-1 condition were lower than the HEPA-2 condition at all decay times (10, 20, and 30 min). Therefore, the overall performance of HEPA-1 was found to be superior to HEPA-2. This is expected as HEPA-1 has a higher CADR number, filter size, and air intake dimensions. <xref rid="F4" ref-type="fig">Figure 4</xref> shows average particle concentrations and statistical differences for all conditions and phases.</p></sec><sec id="S21"><title>Overall percentage reduction of particle concentration</title><p id="P34">The percentages of reduction of the baseline case, HEPA-1 and HEPA-2 were calculated and are shown in <xref rid="T1" ref-type="table">Table 1</xref>. The concentration used to calculate the percentages of reduction was the mean concentration of aerosol generation of the baseline case (18.3 particles/L). This phase was considered the experimental control since it did not use any HEPA filtration unit intervention. For that reason, the reduction percentage reported in <xref rid="T1" ref-type="table">Table 1</xref> for that phase and test condition (baseline aerosol generation phase) is zero.</p><p id="P35">After 10 min, the baseline case had an overall reduction of particle concentration of approximately 61%, and after 20 min, greater than 100% (<xref rid="T1" ref-type="table">Table 1</xref>).</p><p id="P36">HEPA-1 had a reduction of approximately 55% during aerosol generation, and over 100% after 10 min, continuing to reduce the concentrations throughout the end of the decay phase. On a similar note, HEPA-2 had a reduction of approximately 46% during the aerosol generation phase, a reduction of 90% after 10 min, and a reduction of greater than 100% after 20 min.</p></sec><sec id="S22"><title>Sulfur hexafluoride (SF<sub>6</sub>) concentration</title><p id="P37">The collected tracer gas decay curve was used to estimate an air change rate for the patient module. The line of best fit was added over the plot of the natural log of SF<sub>6</sub> concentration <italic toggle="yes">vs</italic>. time in hours (hr) for the subset of the curve starting at the peak of the concentration and ending at 1% of the peak concentration. The slope of this calculated line of best fit was used as the estimated air change rate in air changes per hour (ACH). The graphs of all six replicates and their calculated line of best fit are shown in <xref rid="F5" ref-type="fig">Figure 5</xref>. An average ACH of 6 was measured.</p></sec></sec><sec id="S23"><title>Discussion</title><p id="P38">The present study aimed to evaluate a HEPA filtration intervention to reduce aerosol concentrations inside the ambulance patient module. Two portable HEPA filtration units were placed one at a time inside the patient module. To simulate a real-life exposure scenario for EMS personnel, droplet nuclei were generated as a tracer aerosol originating from two medical nebulizers positioned near the mouth of a patient mannequin. Aerosol &#x0201c;exposure&#x0201d; concentrations were measured using four OPCs strategically placed at the breathing zone levels of EMS seat locations within the patient module. To obtain further information regarding airflow behavior, tracer gas tests using SF<sub>6</sub> were performed to obtain air change rates inside the patient module.</p><sec id="S24"><title>Portable HEPA filtration units</title><p id="P39">The two portable HEPA filtration units evaluated in this study were from different manufacturers and varied in CADR and induced airflow parameters. Therefore, several factors resulted in observed differences in particle concentrations inside the ambulance patient module using the portable HEPA units. For example, HEPA-1 has a higher CADR of 172 cfm (smoke), while HEPA-2 has a CADR of 99 cfm (smoke). The CADR standardized measurement system is used to rate the performance of air cleaners (<xref rid="R15" ref-type="bibr">Environmental Protection Agency 2021</xref>). Participating manufacturers certify their air purifiers through the Association of Home Appliance Manufacturers (AHAM) which evaluates the performance of the unit for removing air pollutants such as tobacco smoke, dust, and pollen following a specified test protocol (<xref rid="R2" ref-type="bibr">Association of Home Appliance Manufacturers 2021</xref>). The AHAM certification includes three CADR numbers (tobacco smoke, dust, and pollen) for each air cleaner. The CADR number provides the volume of effectively filtered air delivered by the air cleaner. The higher the number, the faster it removes the contaminant. The CADR number of interest for this study was the tobacco smoke that has a particle size from around 0.1 &#x003bc;m to 1 &#x003bc;m (<xref rid="R21" ref-type="bibr">Keith and Derrick 1960</xref>).</p><p id="P40">This space within the patient module was limited with walls on three sides. Therefore, the location and orientation could influence filtration performance. Further experiments or modeling of portable HEPA filtration units in different locations or orientations inside the patient module could provide additional information on how location could impact the performance of the HEPA filtration unit in an ambulance and the ability to effectively reduce worker exposures.</p></sec><sec id="S25"><title>Experimental protocol</title><p id="P41">Aerosol-generating procedures such as intubation are often not recommended in prehospital environments (<xref rid="R18" ref-type="bibr">Gnugnoli and Shafer 2023</xref>). One of the challenges behind this recommendation is the level of expertise required to perform intubation, for example between non-physician and physician providers. Complications during airway interventions may emerge and result in failed patient intubation (<xref rid="R31" ref-type="bibr">Lockey et al. 2015</xref>). Moreover, prehospital intubation can have other complications such as hypoxia, hypotension, tracheal tube misplacement, esophageal intubation, vomiting and aspiration, cardiac arrhythmia, bleeding, and dental damage (<xref rid="R12" ref-type="bibr">Crewdson et al. 2017</xref>). Nevertheless, there are situations when the EMS provider may perform airway interventions such as during cardiac arrest or as otherwise determined by the EMS provider (<xref rid="R13" ref-type="bibr">Crewdson et al. 2018</xref>). We evaluated the generation of infectious aerosols in spike concentrations instead of constant concentration to simulate the intubation or another aerosol-generating procedure. Typically, patient intubation should take around 30 s (<xref rid="R25" ref-type="bibr">Lane et al. 2004</xref>). However, it was important to evaluate the transient behavior immediately following the spike concentration using the filtration units, thus the analysis covered 30 min after intubation to capture the longer-term effect of an aerosol-generating procedure. However, if a HEPA filter unit is installed inside the ambulance cabin, it should be always running during patient transport, especially during the respiratory virus season, not just during aerosol-generating procedures.</p><p id="P42">The protocol for the aerosol generation phase was generally the same for the baseline case, HEPA-1, and HEPA-2 with the addition of the portable HEPA filtration units which were turned on during the corresponding conditions. It was expected that both HEPA conditions would have significant reductions in particle concentration during the aerosol generation phase (phase 2). The baseline case demonstrated the natural decay curve, while the inclusion of HEPA filtration units demonstrated the performance of an intervention to reduce aerosol concentrations within the patient module. The HEPA-1 and HEPA-2 conditions performed better than the baseline case, and HEPA-1 exhibited better performance among the two HEPA filtration units. This was expected as HEPA-1 had a larger CADR, delivering 72% more clean air than HEPA-2.</p><p id="P43">The standard deviation was very high in the statistical analysis. It is possible that the 5-min duration of the aerosol generation phase (phase 2) might not be enough to provide a homogenous aerosol distribution among the four OPCs inside the module. This may have contributed to the high standard deviation between OPCs. The smaller sampling time of 6 s may be another cause. However, increasing the time of the aerosol generation phase (phase 2) would not be realistic because the experimental protocol aims to mimic aerosol-generating procedures, such as the intubation process that may take a few seconds to a minute to perform. Moreover, these differences in aerosol concentrations inside the patient module also reflect differences in exposure among locations within the patient module which is not in a perfectly-mixed space under steady state.</p><p id="P44">Another important aspect to consider is the assessment of background concentration. Background concentrations were obtained during the background particle removal phase (phase 1), and the last 3 min were averaged as the background concentration level to be removed. This background correction enabled the experiment to better focus on the concentration build-up and decay of the tracer aerosols generated within the patient module. The background concentrations were averaged and subtracted from the original raw data. This resulted in negative numbers in some cases as the presence of the HEPA filtration units cleaned the air, beyond what was occurring in the natural environment to below background.</p><p id="P45">Finally, temperature is another factor that may affect airflow patterns. As mentioned before, the ambulance used in this study had a heating and cooling system. The air was recirculated and there was no outside air intake. To minimize changes in air patterns, the heating was turned on during the cold season, and the cooling system was turned on during the hot season. This way, temperature differences were incorporated into the average aerosol reduction in a real-world way. The heating and cooling system always operated on the highest airflow setting, and given the recirculating nature of the system, it should not have contributed meaningfully to the particle reduction. However, changing the fan setting could change pressure imbalances and thus air infiltration rates. Leaving the system set to high eliminated this variable.</p></sec><sec id="S26"><title>Findings</title><p id="P46">The performance of the HEPA filtration units was evaluated during two distinct experimental stages, the aerosol generation phase, and the decay phase. During the aerosol generation phase, which mimicked a concentration buildup such as during an aerosol-generating procedure, the HEPA test conditions revealed protective exposure reductions exceeding 55% (HEPA-1) and 46% (HEPA-2). Data analyses over three time periods of decay (10, 20, and 30 min) were conducted to assess the HEPA filtration units &#x02018;ability to dilute a contaminant concentration once it was generated. At 20 and 30 min, all three conditions were below the background. By examining the concentrations at 10 and 20 min, it was observed that HEPA filtration units reduced aerosol concentrations below background concentration much faster than the baseline case. This was especially evident in the first 10 min following the aerosol generation phase, thus reducing both the short-term peak aerosol exposure as well as the total exposure over the 30-min test period.</p></sec><sec id="S27"><title>Air infiltration</title><p id="P47">A tracer gas test with sulfur hexafluoride (SF<sub>6</sub>) was performed to check for any leaks in the patient module that might dilute the inside aerosol concentration. The patient module and driver module did not share an HVAC system and the air movement between the driver and patient module was reduced as much as reasonable. An average of 6 air changes per hour (ACH) was observed, which is high for a sealed vehicle. Therefore, the baseline case had a fast natural decay despite sealing the ambulance at all ports and cracks between the driver&#x02019;s compartment and the patient module. Both the aerosol and tracer gas tests indicated appreciable air leakage into the ambulance patient module that could not be fully mitigated. The high air exchange rate measured in the ambulance module during the tracer gas decay test was likely to be attributed to two primary factors. First, the ambulance module was not completely airtight, allowing for some air leakage even with the doors closed and sealing efforts in place. Second, the HVAC system within the module likely generated airflow and pressure imbalances, which could have exacerbated the air leakage. In the small internal air volume of the ambulance module, even minor air leakage can contribute to a substantially higher air exchange rate compared to what would occur from similar leakage in larger volume spaces. The research vehicle in which the tests were conducted was over 15 years old and leaks within the HVAC system pathway are suspected but could not be confirmed. In the absence of such leaks, the protective impact of particle reductions associated with the HEPA interventions would likely be greater. In a real-world scenario, an ambulance would also have air movement from and to the exterior, perhaps even greater than was found in this research vehicle. This would serve to further dilute any infectious aerosols inside the cabin. Thus, current results may be conservative while real-world aerosol decay may occur faster. Future research could validate this assertion.</p><p id="P48">Although portable HEPA filtration units have not yet been broadly implemented in ambulances, there are a few examples of real-life applications. One study evaluated a high-efficiency cabin air (HECA) system installed inside a school bus and found that it effectively reduced the exposure to vehicle pollutants among children. Other groups are studying containment and filtration systems for potential use in ambulances (<xref rid="R11" ref-type="bibr">Cranfield University 2021</xref>; <xref rid="R33" ref-type="bibr">Lyng 2021</xref>; <xref rid="R24" ref-type="bibr">Klein Leichman 2022</xref>). However, to the authors&#x02019; knowledge, more studies with concrete data have not been published.</p><p id="P49">Further research could include (a) evaluating different HEPA unit orientations, inlet/outlet modifications, and locations inside the ambulance to determine filtration performance, (b) performing the experiments in a more controlled indoor environment removing all background concentrations, and (c) evaluating the portable HEPA units with culturable infectious aerosols instead of a tracer aerosol surrogate. Additional tests should be performed to ensure that the HEPA filtration units are safely secured when used with the vehicle moving, as is required for all equipment in the cabin. The vehicle moving at speed may induce air pressure gradients around the outside of the cabin that will affect air infiltration rates and thus particle clearance times. There will also be other inertial air effects from vehicle motion that would be less likely to impact ventilation effectiveness but could change air distribution patterns and worker breathing zone concentrations. Future research should help to quantify the effect of these variables.</p></sec></sec><sec id="S28"><title>Limitations</title><p id="P50">While the findings show a possible intervention to reduce worker exposure to bioaerosols, there were limitations to this study. These included: (1) stationary operation of the vehicle, (2) modified ambulance inlet and outlets, (3) use of a monodispersed non-biological aerosol surrogate, (4) testing of two HEPA filtration units that were unsecured. Further research could address and quantify these limitations by: (a) evaluating different HEPA unit orientations, inlet/outlet modifications, and locations inside the ambulance to determine filtration performance, (b) performing the experiments in a more controlled indoor environment removing all background concentrations while minimizing changes to ambulance air inlets/outlets, (c) evaluating the portable HEPA units with culturable infectious aerosols instead of a tracer aerosol surrogate, and (d) ensuring that the HEPA filtrations units are safely secured when using with the vehicle moving, as is required for all equipment in the cabin. The vehicle moving at speed may induce air pressure gradients around the outside of the cabin that will affect air infiltration rates and thus particle clearance times. There will also be other inertial air effects from vehicle motion that would be less likely to impact ventilation effectiveness but could change air distribution patterns and worker breathing zone concentrations.</p></sec><sec id="S29"><title>Conclusions</title><p id="P51">Overall, this study showed that the use of HEPA filter units helped reduce aerosol concentrations inside the patient module of an ambulance, both during the aerosol generation phase and during the post-generation decay phase. Air flow direction, HEPA filter unit sizes, and CADR ratings are all characteristics that may be considered when choosing an air cleaner as well as the location to be safely placed inside the patient module. Even though the performance of the evaluated HEPA units varied, the HEPA units significantly reduced particle concentrations during aerosol generation by around 50% and continued to do so until the end of the decay period. Although some ambulance manufacturers offer HEPA filtration systems integrated into the design of new ambulances, their adoption has not been widespread, possibly due to the loss of airflow resulting from the HEPA filter&#x02019;s large pressure drop. At least one company offers a HEPA retrofit kit for existing ambulance patient modules. As awareness increases of the role ventilation plays in reducing infectious aerosols, this may become a more requested option, but it takes time to replace the nation&#x02019;s ambulance fleet with HEPA-filtered patient modules. Portable HEPA air cleaners could be a temporary option to reduce the exposures of EMS providers inside the patient module, especially during a pandemic response.</p></sec><sec sec-type="data-availability" id="S30"><title>Data availability statement</title><p id="P52">The data that support the findings of this study are available from the corresponding author, reasonable request.</p></sec></body><back><ack id="S31"><title>Acknowledgments</title><p id="P53">The authors would like to acknowledge the support of the Engineering and Physical Hazards Branch at NIOSH Cincinnati by providing all the laboratory equipment. This project was partly supported by the Research Participation Program at the Centers for Disease Control and Prevention, administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S. Department of Energy and the Centers for Disease Control and Prevention. The authors would like to thank Stephen Martin, Andrea Wilkinson, Ryan LeBouf, Deborah Hirst, and Shreyash Manegaonkar for reviewing the article.</p><sec id="S32"><title>Funding</title><p id="P54">The ORISE fellowship was funded with number 21FED2100092OHK. This research was funded by the Disaster Science Responder Research Program (DSRR) in the Emergency Preparedness and Response Office (EPRO) of the US Centers for Disease Control and Prevention (CDC). The National Institute for Occupational Safety and Health (NIOSH) is a part of the CDC. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of NIOSH, CDC. Mention of any company or product does not constitute endorsement by NIOSH, CDC.</p></sec></ack><fn-group><fn id="FN2"><p id="P55">This work was authored as part of the Contributor&#x02019;s official duties as an Employee of the United States Government and is therefore a work of the United States Government. In accordance with 17 U.S.C. 105, no copyright protection is available for such works under U.S. Law.</p></fn><fn fn-type="COI-statement" id="FN3"><p id="P56">Disclosure statement</p><p id="P57">No potential conflict of interest was reported by the author(s).</p></fn></fn-group><ref-list><title>References</title><ref id="R1"><mixed-citation publication-type="journal"><collab>Ambulancemed</collab>. <year>2023</year>. <source>Infection type ambulance</source>; [accessed <date-in-citation>2023 Nov 21</date-in-citation>]. <ext-link xlink:href="https://ambulancemed.com/urun/ambulancemed-infection-type-ambulance/" ext-link-type="uri">https://ambulancemed.com/urun/ambulancemed-infection-type-ambulance/</ext-link>.</mixed-citation></ref><ref id="R2"><mixed-citation publication-type="journal"><collab>Association of Home Appliance Manufacturers</collab>. <year>2021</year>. <source>AHAM&#x02019;s air filtration standard</source>. <ext-link xlink:href="https://ahamverifide.org/ahams-air-filtrations-standards%e2%80%a8/" ext-link-type="uri">https://ahamverifide.org/ahams-air-filtrations-standards%e2%80%a8/</ext-link>.</mixed-citation></ref><ref id="R3"><mixed-citation publication-type="journal"><name><surname>Bluyssen</surname><given-names>PM</given-names></name>, <name><surname>Ortiz</surname><given-names>M</given-names></name>, <name><surname>Zhang</surname><given-names>D</given-names></name>. <year>2021</year>. <article-title>The effect of a mobile HEPA filter system on &#x0201c;infectious&#x0201d; aerosols, sound and air velocity in the SenseLab</article-title>. <source>Build Environ</source>
<volume>188</volume>:<fpage>107475</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.buildenv.2020.107475</pub-id>.<pub-id pub-id-type="pmid">33293755</pub-id>
</mixed-citation></ref><ref id="R4"><mixed-citation publication-type="journal"><name><surname>Buick</surname><given-names>JE</given-names></name>, <name><surname>Cheskes</surname><given-names>S</given-names></name>, <name><surname>Feldman</surname><given-names>M</given-names></name>, <name><surname>Verbeek</surname><given-names>PR</given-names></name>, <name><surname>Hillier</surname><given-names>M</given-names></name>, <name><surname>Leong</surname><given-names>YC</given-names></name>, <name><surname>Drennan</surname><given-names>IR</given-names></name>. <year>2020</year>. <article-title>COVID-19: What paramedics need to know!</article-title>
<source>CJEM</source>
<volume>22</volume>(<issue>4</issue>):<fpage>426</fpage>&#x02013;<lpage>430</lpage>. doi: <pub-id pub-id-type="doi">10.1017/cem.2020.367</pub-id>.<pub-id pub-id-type="pmid">32290887</pub-id>
</mixed-citation></ref><ref id="R5"><mixed-citation publication-type="journal"><name><surname>Cadnum</surname><given-names>JL</given-names></name>, <name><surname>Bolomey</surname><given-names>A</given-names></name>, <name><surname>Jencson</surname><given-names>AL</given-names></name>, <name><surname>Wilson</surname><given-names>BM</given-names></name>, <name><surname>Donskey</surname><given-names>CJ</given-names></name>. <year>2023</year>. <article-title>Effectiveness of commercial portable air cleaners and a do-it-yourself minimum efficiency reporting value (MERV)-13 filter box fan air cleaner in reducing aerosolized bacteriophage MS2</article-title>. <source>Infect Control Hosp Epidemiol</source>
<volume>44</volume>(<issue>4</issue>):<fpage>663</fpage>&#x02013;<lpage>665</lpage>. doi: <pub-id pub-id-type="doi">10.1017/ice.2022.5</pub-id>.<pub-id pub-id-type="pmid">35098916</pub-id>
</mixed-citation></ref><ref id="R6"><mixed-citation publication-type="journal"><collab>Centers for Disease Control and Prevention</collab>. <year>2019</year>. <source>Interim infection prevention and control recommendations for measles in healthcare settings</source>. Last modified July 23, 2019; [accessed <date-in-citation>2022 Nov 21</date-in-citation>]. <ext-link xlink:href="https://www.cdc.gov/infectioncontrol/guidelines/measles/index.html" ext-link-type="uri">https://www.cdc.gov/infectioncontrol/guidelines/measles/index.html</ext-link>.</mixed-citation></ref><ref id="R7"><mixed-citation publication-type="journal"><collab>Centers for Disease Control and Prevention</collab>. <year>2021</year>. <source>Efficacy of portable air cleaners and masking for reducing indoor exposure to simulated exhaled SARS-CoV-2 aerosols&#x02014;United States, 2021</source>; [accessed <date-in-citation>2022 Nov 21</date-in-citation>]. <ext-link xlink:href="https://www.cdc.gov/mmwr/volumes/70/wr/mm7027e1.htm" ext-link-type="uri">https://www.cdc.gov/mmwr/volumes/70/wr/mm7027e1.htm</ext-link>.</mixed-citation></ref><ref id="R8"><mixed-citation publication-type="journal"><collab>Centers for Disease Control and Prevention</collab>. <year>2023</year>. <source>Interim infection prevention and control recommendations for healthcare personnel during the coronavirus disease 2019 (COVID-19) pandemic</source>; [accessed <date-in-citation>2023 Nov 28</date-in-citation>]. <ext-link xlink:href="https://www.cdc.gov/coronavirus/2019-ncov/hcp/infection-control-recommendations.html" ext-link-type="uri">https://www.cdc.gov/coronavirus/2019-ncov/hcp/infection-control-recommendations.html</ext-link>.</mixed-citation></ref><ref id="R9"><mixed-citation publication-type="journal"><name><surname>Chen</surname><given-names>C</given-names></name>, <name><surname>Zhao</surname><given-names>B</given-names></name>, <name><surname>Cui</surname><given-names>W</given-names></name>, <name><surname>Dong</surname><given-names>L</given-names></name>, <name><surname>An</surname><given-names>N</given-names></name>, <name><surname>Ouyang</surname><given-names>X</given-names></name>. <year>2010</year>. <article-title>The effectiveness of an air cleaner in controlling droplet/aerosol particle dispersion emitted from a patient&#x02019;s mouth in the indoor environment of dental clinics</article-title>. <source>J R Soc Interface</source>. <volume>7</volume>(<issue>48</issue>):<fpage>1105</fpage>&#x02013;<lpage>1118</lpage>. doi: <pub-id pub-id-type="doi">10.1098/rsif.2009.0516</pub-id>.<pub-id pub-id-type="pmid">20031985</pub-id>
</mixed-citation></ref><ref id="R10"><mixed-citation publication-type="journal"><name><surname>Cox</surname><given-names>J</given-names></name>, <name><surname>Isiugo</surname><given-names>K</given-names></name>, <name><surname>Ryan</surname><given-names>P</given-names></name>, <name><surname>Grinshpun</surname><given-names>SA</given-names></name>, <name><surname>Yermakov</surname><given-names>M</given-names></name>, <name><surname>Desmond</surname><given-names>C</given-names></name>, <name><surname>Jandarov</surname><given-names>R</given-names></name>, <name><surname>Vesper</surname><given-names>S</given-names></name>, <name><surname>Ross</surname><given-names>J</given-names></name>, <name><surname>Chillrud</surname><given-names>S</given-names></name>, <etal/>
<year>2018</year>. <article-title>Effectiveness of a portable air cleaner in removing aerosol particles in homes close to highways</article-title>. <source>Indoor Air</source>. <volume>28</volume>(<issue>6</issue>):<fpage>818</fpage>&#x02013;<lpage>827</lpage>. doi: <pub-id pub-id-type="doi">10.1111/ina.12502</pub-id>.<pub-id pub-id-type="pmid">30133950</pub-id>
</mixed-citation></ref><ref id="R11"><mixed-citation publication-type="journal"><collab>Cranfield University</collab>. <year>2021</year>. <source>New research to enhance air filtering in ambulances</source>. [Online] <ext-link xlink:href="https://www.cranfield.ac.uk/press/news-2021/new-research-to-enhance-air-filtering-in-ambulances" ext-link-type="uri">https://www.cranfield.ac.uk/press/news-2021/new-research-to-enhance-air-filtering-in-ambulances</ext-link>.</mixed-citation></ref><ref id="R12"><mixed-citation publication-type="journal"><name><surname>Crewdson</surname><given-names>K</given-names></name>, <name><surname>Lockey</surname><given-names>DJ</given-names></name>, <name><surname>R&#x000f8;islien</surname><given-names>J</given-names></name>, <name><surname>Lossius</surname><given-names>HM</given-names></name>, <name><surname>Rehn</surname><given-names>M</given-names></name>. <year>2017</year>. <article-title>The success of pre-hospital tracheal intubation by different pre-hospital providers: a systematic literature review and meta-analysis</article-title>. <source>Crit Care</source>. <volume>21</volume>(<issue>1</issue>):<fpage>31</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s13054-017-1603-7</pub-id>.<pub-id pub-id-type="pmid">28196506</pub-id>
</mixed-citation></ref><ref id="R13"><mixed-citation publication-type="journal"><name><surname>Crewdson</surname><given-names>K</given-names></name>, <name><surname>Rehn</surname><given-names>M</given-names></name>, <name><surname>Lockey</surname><given-names>D</given-names></name>. <year>2018</year>. <article-title>Airway management in pre-hospital critical care: a review of the evidence for a &#x0201c;top five&#x0201d; research priority</article-title>. <source>Scand J Trauma Resusc Emerg Med</source>
<volume>26</volume>(<issue>1</issue>):<fpage>89</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s13049-018-0556-4</pub-id>.<pub-id pub-id-type="pmid">30342543</pub-id>
</mixed-citation></ref><ref id="R14"><mixed-citation publication-type="journal"><name><surname>El-Boghdadly</surname><given-names>K</given-names></name>, <name><surname>Wong</surname><given-names>DJN</given-names></name>, <name><surname>Owen</surname><given-names>R</given-names></name>, <name><surname>Neuman</surname><given-names>MD</given-names></name>, <name><surname>Pocock</surname><given-names>S</given-names></name>, <name><surname>Carlisle</surname><given-names>JB</given-names></name>, <name><surname>Johnstone</surname><given-names>C</given-names></name>, <name><surname>Andruszkiewicz</surname><given-names>P</given-names></name>, <name><surname>Baker</surname><given-names>PA</given-names></name>, <name><surname>Biccard</surname><given-names>BM</given-names></name>, <etal/>
<year>2020</year>. <article-title>Risks to healthcare workers following tracheal intubation of patients with COVID-19: a prospective international multicenter cohort study</article-title>. <source>Anaesthesia</source>. <volume>75</volume>(<issue>11</issue>):<fpage>1437</fpage>&#x02013;<lpage>1447</lpage>. doi: <pub-id pub-id-type="doi">10.1111/anae.15170</pub-id>.<pub-id pub-id-type="pmid">32516833</pub-id>
</mixed-citation></ref><ref id="R15"><mixed-citation publication-type="book"><collab>Environmental Protection Agency</collab>. <year>2021</year>. <source>Air cleaners, HVAC filters, and coronavirus (COVID-19)</source>. <publisher-name>EPA</publisher-name>; [accessed <date-in-citation>2021 Aug 3</date-in-citation>]. <ext-link xlink:href="https://www.epa.gov/coronavirus/air-cleaners-hvac-filters-and-coronavirus-covid-19" ext-link-type="uri">https://www.epa.gov/coronavirus/air-cleaners-hvac-filters-and-coronavirus-covid-19</ext-link>.</mixed-citation></ref><ref id="R16"><mixed-citation publication-type="book"><collab>Environmental Protection Agency</collab>. <year>2023</year>. <source>What is a HEPA filter?</source>
<publisher-name>EPA</publisher-name>; [accessed <date-in-citation>2021 Aug 3</date-in-citation>]. <ext-link xlink:href="https://www.epa.gov/indoor-air-quality-iaq/what-hepa-filter-1" ext-link-type="uri">https://www.epa.gov/indoor-air-quality-iaq/what-hepa-filter-1</ext-link>.</mixed-citation></ref><ref id="R17"><mixed-citation publication-type="journal"><name><surname>Estill</surname><given-names>C</given-names></name>
<year>1999</year>. <source>Chapter 9: Ergonomics, in Aiha engineering reference manual</source>.</mixed-citation></ref><ref id="R18"><mixed-citation publication-type="book"><name><surname>Gnugnoli</surname><given-names>DSA</given-names></name>, <name><surname>Shafer</surname><given-names>K</given-names></name>. <year>2023</year>. <source>EMS field intubation</source> (<publisher-name>S. Publishing</publisher-name> Ed.). <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK538221/" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/books/NBK538221/</ext-link>.</mixed-citation></ref><ref id="R19"><mixed-citation publication-type="journal"><name><surname>Heo</surname><given-names>KJ</given-names></name>, <name><surname>Park</surname><given-names>I</given-names></name>, <name><surname>Lee</surname><given-names>G</given-names></name>, <name><surname>Hong</surname><given-names>K</given-names></name>, <name><surname>Han</surname><given-names>B</given-names></name>, <name><surname>Jung</surname><given-names>JH</given-names></name>, <name><surname>Kim</surname><given-names>SB</given-names></name>. <year>2021</year>. <article-title>Effects of air purifiers on the spread of simulated respiratory droplet nuclei and virus aggregates</article-title>. <source>Int J Environ Res Public Health</source>. <volume>18</volume>(<issue>16</issue>):<fpage>8426</fpage>. doi: <pub-id pub-id-type="doi">10.3390/ijerph18168426</pub-id>.<pub-id pub-id-type="pmid">34444175</pub-id>
</mixed-citation></ref><ref id="R20"><mixed-citation publication-type="journal"><collab>Horton Ambulances</collab>. <year>2021</year>. <source>Ambulance models</source>; [accessed <date-in-citation>2021 Aug 3</date-in-citation>]. <ext-link xlink:href="https://www.hortonambulance.com/high-risk-infection-control-ambulance" ext-link-type="uri">https://www.hortonambulance.com/high-risk-infection-control-ambulance</ext-link>.</mixed-citation></ref><ref id="R21"><mixed-citation publication-type="journal"><name><surname>Keith</surname><given-names>CH</given-names></name>, <name><surname>Derrick</surname><given-names>JC</given-names></name>. <year>1960</year>. <article-title>Measurement of the particle size distribution and concentration of cigarette smoke by the &#x0201c;conifuge&#x0201d;</article-title>. <source>J Colloid Sci</source>
<volume>15</volume>(<issue>4</issue>):<fpage>340</fpage>&#x02013;<lpage>356</lpage>. doi: <pub-id pub-id-type="doi">10.1016/0095-8522(60)90037-4</pub-id>.</mixed-citation></ref><ref id="R22"><mixed-citation publication-type="journal"><name><surname>Kibira</surname><given-names>D</given-names></name>, <name><surname>Lee</surname><given-names>Y-T</given-names></name>, <name><surname>Barnard</surname><given-names>A</given-names></name>, <name><surname>Marshall</surname><given-names>J</given-names></name>, <name><surname>Avery</surname><given-names>L</given-names></name>, <name><surname>Moore</surname><given-names>J</given-names></name>, <name><surname>Boone</surname><given-names>C</given-names></name>. <year>2013</year>. <source>Modeling and simulation for improving ambulance patient compartment design standards</source>.</mixed-citation></ref><ref id="R23"><mixed-citation publication-type="book"><name><surname>Kibira</surname><given-names>D</given-names></name>, <name><surname>Tina Lee</surname><given-names>Y</given-names></name>, <name><surname>Dadfarnia</surname><given-names>M</given-names></name>. <year>2012</year>. <source>Enhancing performance and safety in ambulances through improved design standards</source>. <publisher-loc>Gaithersburg, MD</publisher-loc>: <publisher-name>National Institute of Standards and Technology</publisher-name>. doi: <pub-id pub-id-type="doi">10.6028/NIST.TN.1741</pub-id>.</mixed-citation></ref><ref id="R24"><mixed-citation publication-type="journal"><name><surname>Klein Leichman</surname><given-names>A</given-names></name>
<year>2022</year>. [Online]. <ext-link xlink:href="https://www.israel21c.org/filter-turns-ambulances-a-c-unit-into-an-air-purifier/" ext-link-type="uri">https://www.israel21c.org/filter-turns-ambulances-a-c-unit-into-an-air-purifier/</ext-link>.</mixed-citation></ref><ref id="R25"><mixed-citation publication-type="journal"><name><surname>Lane</surname><given-names>B</given-names></name>, <name><surname>Finer</surname><given-names>N</given-names></name>, <name><surname>Rich</surname><given-names>W</given-names></name>. <year>2004</year>. <article-title>Duration of intubation attempts during neonatal resuscitation</article-title>. <source>J Pediatr</source>
<volume>145</volume>(<issue>1</issue>): <fpage>67</fpage>&#x02013;<lpage>70</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jpeds.2004.03.003</pub-id>.<pub-id pub-id-type="pmid">15238909</pub-id>
</mixed-citation></ref><ref id="R26"><mixed-citation publication-type="journal"><name><surname>Lee</surname><given-names>BU</given-names></name>. <year>2020</year>. <article-title>Minimum sizes of respiratory particles carrying SARS-CoV-2 and the possibility of aerosol generation</article-title>. <source>Int J Environ Res Public Health</source>. <volume>17</volume>(<issue>19</issue>). doi: <pub-id pub-id-type="doi">10.3390/ijerph17196960</pub-id>.</mixed-citation></ref><ref id="R27"><mixed-citation publication-type="journal"><name><surname>Lee</surname><given-names>ES</given-names></name>, <name><surname>Fung C-</surname><given-names>CD</given-names></name>, <name><surname>Zhu</surname><given-names>Y</given-names></name>. <year>2015</year>. <article-title>Evaluation of a high efficiency cabin air (HECA) filtration system for reducing particulate pollutants inside school buses</article-title>. <source>Environ Sci Technol</source>
<volume>49</volume>(<issue>6</issue>):<fpage>3358</fpage>&#x02013;<lpage>3365</lpage>. doi: <pub-id pub-id-type="doi">10.1021/es505419m</pub-id>.<pub-id pub-id-type="pmid">25728749</pub-id>
</mixed-citation></ref><ref id="R28"><mixed-citation publication-type="journal"><name><surname>Lindsley</surname><given-names>WG</given-names></name>, <name><surname>Blachere</surname><given-names>FM</given-names></name>, <name><surname>McClelland</surname><given-names>TL</given-names></name>, <name><surname>Neu</surname><given-names>DT</given-names></name>, <name><surname>Mnatsakanova</surname><given-names>A</given-names></name>, <name><surname>Martin</surname><given-names>SB</given-names><suffix>Jr.</suffix></name>, <name><surname>Mead</surname><given-names>KR</given-names></name>, <name><surname>Noti</surname><given-names>JD</given-names></name>. <year>2019</year>. <article-title>Efficacy of an ambulance ventilation system in reducing EMS worker exposure to airborne particles from a patient cough aerosol simulator</article-title>. <source>J Occup Environ Hyg</source>
<volume>16</volume>(<issue>12</issue>):<fpage>804</fpage>&#x02013;<lpage>816</lpage>. doi: <pub-id pub-id-type="doi">10.1080/15459624.2019.1674858</pub-id>.<pub-id pub-id-type="pmid">31638865</pub-id>
</mixed-citation></ref><ref id="R29"><mixed-citation publication-type="journal"><name><surname>Lindsley</surname><given-names>WG</given-names></name>, <name><surname>Derk</surname><given-names>RC</given-names></name>, <name><surname>Coyle</surname><given-names>JP</given-names></name>, <name><surname>Martin</surname><given-names>SB</given-names><suffix>Jr.</suffix></name>, <name><surname>Mead</surname><given-names>KR</given-names></name>, <name><surname>Blachere</surname><given-names>FM</given-names></name>, <name><surname>Beezhold</surname><given-names>DH</given-names></name>, <name><surname>Brooks</surname><given-names>JT</given-names></name>, <name><surname>Boots</surname><given-names>T</given-names></name>, <name><surname>Noti</surname><given-names>JD</given-names></name>. <year>2021</year>. <article-title>Efficacy of portable air cleaners and masking for reducing indoor exposure to simulated exhaled SARS-CoV-2 aerosols&#x02014;United States, 2021</article-title>. <source>Morb Mortal Wkly Rep</source>
<volume>70</volume>(<issue>27</issue>):<fpage>972</fpage>&#x02013;<lpage>976</lpage>. doi: <pub-id pub-id-type="doi">10.15585/mmwr.mm7027e1</pub-id>.</mixed-citation></ref><ref id="R30"><mixed-citation publication-type="journal"><name><surname>Liu</surname><given-names>DT</given-names></name>, <name><surname>Phillips</surname><given-names>KM</given-names></name>, <name><surname>Speth</surname><given-names>MM</given-names></name>, <name><surname>Besser</surname><given-names>G</given-names></name>, <name><surname>Mueller</surname><given-names>CA</given-names></name>, <name><surname>Sedaghat</surname><given-names>AR</given-names></name>. <year>2022</year>. <article-title>Portable HEPA purifiers to eliminate airborne SARS-CoV-2: a systematic review</article-title>. <source>Otolaryngol Head Neck Surg</source>
<volume>166</volume>(<issue>4</issue>):<fpage>615</fpage>&#x02013;<lpage>622</lpage>. doi: <pub-id pub-id-type="doi">10.1177/01945998211022636</pub-id>.<pub-id pub-id-type="pmid">34098798</pub-id>
</mixed-citation></ref><ref id="R31"><mixed-citation publication-type="journal"><name><surname>Lockey</surname><given-names>DJ</given-names></name>, <name><surname>Healey</surname><given-names>B</given-names></name>, <name><surname>Crewdson</surname><given-names>K</given-names></name>, <name><surname>Chalk</surname><given-names>G</given-names></name>, <name><surname>Weaver</surname><given-names>AE</given-names></name>, <name><surname>Davies</surname><given-names>GE</given-names></name>. <year>2015</year>. <article-title>Advanced airway management is necessary in prehospital trauma patients</article-title>. <source>Br J Anaesth</source>
<volume>114</volume>(<issue>4</issue>): <fpage>657</fpage>&#x02013;<lpage>662</lpage>. doi: <pub-id pub-id-type="doi">10.1093/bja/aeu412</pub-id>.<pub-id pub-id-type="pmid">25540067</pub-id>
</mixed-citation></ref><ref id="R32"><mixed-citation publication-type="journal"><name><surname>Luo</surname><given-names>M</given-names></name>, <name><surname>Cao</surname><given-names>S</given-names></name>, <name><surname>Wei</surname><given-names>L</given-names></name>, <name><surname>Tang</surname><given-names>R</given-names></name>, <name><surname>Hong</surname><given-names>S</given-names></name>, <name><surname>Liu</surname><given-names>R</given-names></name>, <name><surname>Wang</surname><given-names>Y</given-names></name>. <year>2020</year>. <article-title>Precautions for intubating patients with COVID-19</article-title>. <source>Anesthesiology</source>. <volume>132</volume>(<issue>6</issue>):<fpage>1616</fpage>&#x02013;<lpage>1618</lpage>. doi: <pub-id pub-id-type="doi">10.1097/aln.0000000000003288</pub-id>.<pub-id pub-id-type="pmid">32195703</pub-id>
</mixed-citation></ref><ref id="R33"><mixed-citation publication-type="journal"><name><surname>Lyng</surname><given-names>JW</given-names></name>. <year>2021</year>. <source>Development of a negative pressure isolation system for containment, filtration, and disinfection of airborne diseases for use in hospitals, ambulances, and alternate care settings. 2021 design of medical devices conference</source>. doi: <pub-id pub-id-type="doi">10.1115/DMD2021-1077</pub-id>.</mixed-citation></ref><ref id="R34"><mixed-citation publication-type="journal"><name><surname>Maudet</surname><given-names>L</given-names></name>, <name><surname>Sarasin</surname><given-names>F</given-names></name>, <name><surname>Dami</surname><given-names>F</given-names></name>, <name><surname>Carron</surname><given-names>PN</given-names></name>, <name><surname>Pasquier</surname><given-names>M</given-names></name>. <year>2020</year>. <article-title>Emergency medical services: COVID-19 crisis</article-title>. <source>Rev Med Suisse</source>. <volume>16</volume>:<fpage>810</fpage>&#x02013;<lpage>814</lpage>.<pub-id pub-id-type="pmid">32348041</pub-id>
</mixed-citation></ref><ref id="R35"><mixed-citation publication-type="journal"><name><surname>Mead</surname><given-names>K</given-names></name>, <name><surname>Johnson</surname><given-names>DL</given-names></name>. <year>2004</year>. <article-title>An evaluation of portable high-efficiency particulate air filtration for expedient patient isolation in epidemic and emergency response</article-title>. <source>Ann Emerg Med</source>
<volume>44</volume>(<issue>6</issue>):<fpage>635</fpage>&#x02013;<lpage>645</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.annemergmed.2004.07.451</pub-id>.<pub-id pub-id-type="pmid">15573040</pub-id>
</mixed-citation></ref><ref id="R36"><mixed-citation publication-type="book"><collab>National Center for Immunization and Respiratory Diseases (NCIRD)</collab>. <year>2022</year>. <source>How COVID-19 spreads</source>. <publisher-name>Centers for Disease Control and Prevention</publisher-name>; [accessed <date-in-citation>2023 Nov 21</date-in-citation>]. <ext-link xlink:href="https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/how-covid-spreads.html" ext-link-type="uri">https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/how-covid-spreads.html</ext-link>.</mixed-citation></ref><ref id="R37"><mixed-citation publication-type="journal"><name><surname>Ng</surname><given-names>K</given-names></name>, <name><surname>Poon</surname><given-names>BH</given-names></name>, <name><surname>Kiat Puar</surname><given-names>TH</given-names></name>, <name><surname>Shan Quah</surname><given-names>JL</given-names></name>, <name><surname>Loh</surname><given-names>WJ</given-names></name>, <name><surname>Wong</surname><given-names>YJ</given-names></name>, <name><surname>Tan</surname><given-names>TY</given-names></name>, <name><surname>Raghuram</surname><given-names>J</given-names></name>. <year>2020</year>. <article-title>COVID-19 and the risk to health care workers: a case report</article-title>. <source>Ann Intern Med</source>
<volume>172</volume>(<issue>11</issue>):<fpage>766</fpage>&#x02013;<lpage>767</lpage>. doi: <pub-id pub-id-type="doi">10.7326/l20-0175</pub-id>.<pub-id pub-id-type="pmid">32176257</pub-id>
</mixed-citation></ref><ref id="R38"><mixed-citation publication-type="journal"><name><surname>Pena</surname><given-names>M</given-names></name>, <name><surname>Neu</surname><given-names>DT</given-names></name>, <name><surname>Feng</surname><given-names>HA</given-names></name>, <name><surname>Hammond</surname><given-names>DR</given-names></name>, <name><surname>Mead</surname><given-names>KR</given-names></name>, <name><surname>Banerjee</surname><given-names>RK</given-names></name>. <year>2023</year>. <article-title>Use of a negative pressure containment pod within ambulance-workspace during pandemic response</article-title>. <source>J Med Device</source>. <volume>17</volume>(<issue>1</issue>):<fpage>011009</fpage>. doi: <pub-id pub-id-type="doi">10.1115/1.4056694</pub-id>.<pub-id pub-id-type="pmid">36890857</pub-id>
</mixed-citation></ref><ref id="R39"><mixed-citation publication-type="journal"><collab>RMA Group</collab>. <year>2023</year>. <source>RMA special vehicles</source>; [accessed <date-in-citation>2023 Nov 21</date-in-citation>]. <ext-link xlink:href="https://www.rmagroup.net/automotive-4/" ext-link-type="uri">https://www.rmagroup.net/automotive-4/</ext-link>.</mixed-citation></ref><ref id="R40"><mixed-citation publication-type="journal"><collab>Webasto Thermo &#x00026; Comfort</collab>. <year>2023</year>. <source>Webasto air filtration system</source>; [accessed <date-in-citation>2023 Nov 21</date-in-citation>]. <ext-link xlink:href="https://www.webasto-comfort.com/int/content/air-filtration-system/" ext-link-type="uri">https://www.webasto-comfort.com/int/content/air-filtration-system/</ext-link>.</mixed-citation></ref><ref id="R41"><mixed-citation publication-type="journal"><name><surname>Weissman</surname><given-names>DN</given-names></name>, <name><surname>de Perio</surname><given-names>MA</given-names></name>, <name><surname>Radonovich</surname><given-names>LJ</given-names><suffix>Jr.</suffix></name>
<year>2020</year>. <article-title>COVID-19 and risks posed to personnel during endotracheal intubation</article-title>. <source>JAMA</source>
<volume>323</volume>(<issue>20</issue>):<fpage>2027</fpage>&#x02013;<lpage>2028</lpage>. doi: <pub-id pub-id-type="doi">10.1001/jama.2020.6627</pub-id>.<pub-id pub-id-type="pmid">32338710</pub-id>
</mixed-citation></ref><ref id="R42"><mixed-citation publication-type="book"><collab>Wheeled Coach</collab>. <year>2022</year>. <source>Ambulances for infectious patient transport</source>. <publisher-name>Rev Group Inc</publisher-name>.; [accessed <date-in-citation>2023 Nov 21</date-in-citation>]. <ext-link xlink:href="https://wheeledcoach.com/ambulances/high-risk-infection-control-ambulance/" ext-link-type="uri">https://wheeledcoach.com/ambulances/high-risk-infection-control-ambulance/</ext-link>.</mixed-citation></ref></ref-list></back><floats-group><fig position="float" id="F1"><label>Figure 1.</label><caption><p id="P58">HEPA filtration intervention evaluated during the two sets of experiments: (A) HEPA-1 and HEPA-2 filter area dimensions and (HEPA-1 inlet is on the front of the device, HEPA-2 inlet is on the back of the device). (B) HEPA-1 and HEPA-2 outlet area dimensions (HEPA-1 outlet is on the top of the device, HEPA-2 has 4 outlets, 2 on both the left and right side [only 1 side shown]).</p></caption><graphic xlink:href="nihms-2075764-f0001" position="float"/></fig><fig position="float" id="F2"><label>Figure 2.</label><caption><p id="P59">(A) Ambulance layout is shown. The portable HEPA filter systems (HEPA-1 or HEPA-2) are displayed. The ambulance HVAC system is represented as a fan in the upper left of the patient module and recirculates as well as tempers the air within the patient module. The dotted arrows show the airflow direction of the HVAC system, not the airflow direction of the HEPA filter units. A mannequin is also observed on the patient stretcher with two nebulizer cups as the source for aerosol generation. Four optical particle counters (OPC-1, OPC-2, OPC-3, OPC-4) were placed in four locations inside the ambulance for data acquisition. (B) HEPA filtration unit orientation. Yellow arrows indicate inlet air and green arrows indicate filtered air.</p></caption><graphic xlink:href="nihms-2075764-f0002" position="float"/></fig><fig position="float" id="F3"><label>Figure 3.</label><caption><p id="P60">The 5-point moving average of the raw data from the three experiments is shown in particles/L <italic toggle="yes">vs</italic>. time. (A) baseline, (B) HEPA-1, and (C) HEPA-2. The different phases can be observed: phase 1 (background particle removal), phase 2 (aerosol generation), and phase 3 (decay); (<italic toggle="yes">n</italic> = 6).</p></caption><graphic xlink:href="nihms-2075764-f0003" position="float"/></fig><fig position="float" id="F4"><label>Figure 4.</label><caption><p id="P61">Average particle concentrations in particles/L are shown during the aerosol generation and decay phases for the baseline, HEPA-1, and HEPA-2. One-way ANOVA was performed. Statistical differences are shown with an asterisk (<italic toggle="yes">p</italic> &#x0003c; 0.001); (<italic toggle="yes">n =</italic> 6). Error bars represent the standard deviation.</p></caption><graphic xlink:href="nihms-2075764-f0004" position="float"/></fig><fig position="float" id="F5"><label>Figure 5.</label><caption><p id="P62">Concentration of the SF<sub>6</sub> in parts per million (ppm) over time in hours. 1 to 6 legends indicate trial number (<italic toggle="yes">n</italic> = 6).</p></caption><graphic xlink:href="nihms-2075764-f0005" position="float"/></fig><table-wrap position="float" id="T1"><label>Table 1.</label><caption><p id="P63">Mean particle concentrations (particle/L) and overall percentages of particle reduction for each condition during each phase.</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">Condition</th><th align="center" valign="top" rowspan="1" colspan="1">Baseline</th><th align="center" valign="top" rowspan="1" colspan="1">HEPA-1</th><th align="center" valign="top" rowspan="1" colspan="1">HEPA-2</th></tr></thead><tbody><tr><td rowspan="2" align="left" valign="top" colspan="1">Aerosol generation</td><td align="center" valign="top" rowspan="1" colspan="1">18.28</td><td align="center" valign="top" rowspan="1" colspan="1">8.18</td><td align="center" valign="top" rowspan="1" colspan="1">9.83</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">0%</td><td align="center" valign="top" rowspan="1" colspan="1">55.2%</td><td align="center" valign="top" rowspan="1" colspan="1">46.2%</td></tr><tr><td rowspan="2" align="left" valign="top" colspan="1">10 min decay</td><td align="center" valign="top" rowspan="1" colspan="1">7.17</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;3.46</td><td align="center" valign="top" rowspan="1" colspan="1">1.74</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">60.7%</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003e;100%</td><td align="center" valign="top" rowspan="1" colspan="1">90.4%</td></tr><tr><td rowspan="2" align="left" valign="top" colspan="1">20 min decay</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;2.12</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;5.32</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;2.08</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">&#x0003e;100%</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003e;100%</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003e;100%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">30 min decay</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;1.68</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;1.16</td><td align="center" valign="top" rowspan="1" colspan="1">4.98</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">&#x0003e;100%</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003e;100%</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003e;100%</td></tr></tbody></table></table-wrap></floats-group></article>